目录产品 » Cardiac troponin I (cTnI) Antibody (5C7HC)
Manual
Manual
COAs

cTnI (5C7HC)

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).
询价
V00306-1

咨询产品问题
产品概述
Specificity Specific to Human cTnI.
No cross-reactivity with human cTnT
Clone ID 5C7HC
Epitope 40-50 within cTnI protein
Isotype Recombinant human IgG1 for 5C7HC.
Subclass Recombinant Human IgG1
Host Species Recombinant Human IgG1
Antigen Species Human
返回

产品属性
Conjugation Unconjugated
Production Cultured in vitro under conditions free from animal-derived components
Purification Protein A/G affinity column
Concentration ≥ 2mg/ml
Formulation 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300.
Storage For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
Product Stability
Temperature, Time Result for clones
5C7 6D11 31D 32C
-80°C, 21 days OK
-20°C, 21 days OK
4°C, 21 days OK
20°C, 21 days OK
37°C, 21 days OK
40°C, 21 days OK
Note GenScript can customize this product per customer's request including product size, buffer components, etc.
返回

应用指导
Platform Capture Detection
ELISA 32CD 5C7
32CD+6D11
(mixture for coating)		 5C7
31D 32CD
5C7 6D11
CLIA 24E40HC 5C7HC
32CD+6D11 5C7HC
TRFIA 24E40HC 5C7HC
返回

图例
CTnI (5C7HC)

»

<
>

技术背景
Target Background Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).
返回

有限使用许可与使用限制
有限使用许可与使用限制 This Product is provided under a limited, non-exclusive, non-transferable, and non-sublicensable end-user license strictly limited to the permitted uses set forth in GenScript’s official documentation, quotations, or written agreements. Any use beyond such scope requires GenScript’s prior written authorization or license.
Except as expressly authorized in writing by GenScript, Customer shall not, and shall not permit, procure, enable, or assist any third party to: (a) commercialize or otherwise exploit the Product, including by reselling, distributing, transferring, sublicensing, or otherwise making the Product (including any product incorporating the Product) available to any third party; (b) copy, reproduce, clone, reverse clone, sequence, analyze, characterize, deconstruct, reconstruct, reverse engineer, or otherwise attempt to discover the composition, sequence, structure, binding characteristics, epitope recognition characteristics, or other proprietary features of the Product; (c) modify, derivatize, humanize, optimize, mutate, design around, or generate any variants, derivatives, fragments, substitutes, or functional equivalents of the Product; or (d) use the Product, any information derived therefrom, or any computational, AI-enabled, or sequence-based design method to develop, manufacture, offer for sale, sell, or commercialize any product or service competitive with the Product or GenScript’s products or services.
All intellectual property rights and all rights not expressly granted herein are reserved by GenScript. No rights are granted by implication, estoppel, or otherwise.
返回

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.